Tim Coetzee is the Chief Advocacy, Services and Science Officer at the National Multiple Sclerosis Society. Tim leads all efforts focused on state and federal advocacy, marketing and communications, services and connection programs. He leads staff for the International Progressive MS Alliance – a global collaboration of MS Societies, scientists, the pharmaceutical industry and people with progressive MS.

Join Jenn and Tim as they discuss why advocacy matters and the multiple ways the NMSS works positively for the MS community.

Join the conversation on our MS forums: https://www.multiplesclerosisnewstoday.com/forums/

Follow us on social media:

Instagram - https://www.instagram.com/msnewstoday/

Facebook - https://www.facebook.com/multiplesclerosisnewstoday

Twitter - https://www.twitter.com/msnewstoday

For more news on Multiple Sclerosis visit:

https://www.multiplesclerosisnewstoday.com/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how a study found no increased risks for women with MS or their babies after exposure to Ocrevus before or during pregnancy. He also reads an article about how autologous hematopoietic stem cell transplant, despite risks, may be a viable treatment option for some MS patients.

===================================

Are you interested in learning more about multiple sclerosis? If so, please visit:

https://multiplesclerosisnewstoday.com/

=====================================

To join in on conversations regarding multiple sclerosis, please visit:

https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how NVG-291 was deemed well tolerated, and is allowing enrolment of a second group of volunteers into its clinical trial.

He also reads “The Visible and Invisible Reflections of MS”, from Beth Ullah's column "Through the Looking Glass".

===================================

Are you interested in learning more about multiple sclerosis? If so, please visit:

https://multiplesclerosisnewstoday.com/

=====================================

To join in on conversations regarding multiple sclerosis, please visit:

https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how PIPE-307, a myelin-restoring treatment, was found safe in a Phase 1 clinical trial in 70 healthy adults.

He also reads “31 Days of MS: My Diagnosis Helped Me Find My Purpose”, a story from our #31DaysOfMS initiative.

===================================

Are you interested in learning more about multiple sclerosis? If so, please visit:

https://multiplesclerosisnewstoday.com/

=====================================

To join in on conversations regarding multiple sclerosis, please visit:

https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, explains how people with MS who drink alcohol on a daily basis may be at risk of losing nerve cells more quickly, according to a study.

He also reads “MS News That Caught My Eye Last Week: Keto Diet, Milk and MS, Disability Progression, Neural Sleeve”, from Ed Tobias’ column, "The MS Wire".

===================================

Are you interested in learning more about multiple sclerosis? If so, please visit:

https://multiplesclerosisnewstoday.com/

=====================================

To join in on conversations regarding multiple sclerosis, please visit:

https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how RRMS patients following a low-carb, high-fat diet for 6 months, showed better physical and mental health.

He also reads “MS News That Caught My Eye Last Week: ‘Cog Fog’, Tolebrutinib, Ublituximab, Spinal Atrophy”, from Ed Tobias' column "The MS Wire".

===================================

Are you interested in learning more about multiple sclerosis? If so, please visit:

https://multiplesclerosisnewstoday.com/

=====================================

To join in on conversations regarding multiple sclerosis, please visit:

https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how mice immunized with casein showed a nervous system inflammation and demyelination and how this may explain why MS symptoms can worsen with dairy.

He also reads “31 Days of MS: Living with MS Has Launched My Radical Self-discovery”, a story from our #31DaysOfMS initiative.

===================================

Are you interested in learning more about multiple sclerosis? If so, please visit:

https://multiplesclerosisnewstoday.com/

=====================================

To join in on conversations regarding multiple sclerosis, please visit:

https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, explains how administering NG-01 stem cell therapy directly into the spinal canal of patients with active progressive MS, reduced NfL levels.

Price also reads “MS News That Caught My Eye Last Week: aHSCT, Skin Cancer, Spasticity, NfL Blood Test”, from Ed Tobias' column, "The MS Wire".

===================================

Are you interested in learning more about multiple sclerosis? If so, please visit:

https://multiplesclerosisnewstoday.com/

=====================================

To join in on conversations regarding multiple sclerosis, please visit:

https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, explains how Masitinib significantly slows disability progression in adults with PPMS and non-active SPMS, according to new data.

He also reads the news article, “31 Days of MS: My Daughter’s Diagnosis Has Brought Us Closer” and “31 Days of MS: A New Mindset Made Me Stronger”.

Check out other ’31 Days of MS’ stories here. https://multiplesclerosisnewstoday.com/31-days-of-ms/

===================================

Are you interested in learning more about multiple sclerosis? If so, please visit:

https://multiplesclerosisnewstoday.com/

=====================================

To join in on conversations regarding multiple sclerosis, please visit:

https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, covers how MS patients on Mavenclad are less likely to experience a disease relapse than those on other oral DMTs like Gilenya, Tecfidera, or Aubagio.

He also reads “The Double-Edged Sword of Fatigue Medications”, from Beth Ullah's column "Through the Looking Glass".

===================================

Are you interested in learning more about multiple sclerosis? If so, please visit:

https://multiplesclerosisnewstoday.com/

=====================================

To join in on conversations regarding multiple sclerosis, please visit:

https://multiplesclerosisnewstoday.com/forums/